Giovanni Checcucci

National Enterprise for NanoScience and NanoTechnology

Papers

1

Total Citations

29

H-Index

1

About

Giovanni Checcucci is a leading researcher in antimicrobial photodynamic therapy (aPDT) and biomedical optics, with a focused expertise in developing non-pharmacological strategies to combat antibiotic-resistant infections. His major contribution centers on the innovative use of light-based devices to inactivate pathogenic bacteria, most notably demonstrated in his highly cited 2020 study on the *in vitro* photoinactivation of *Helicobacter pylori* using a novel LED-based device. This work, which has garnered 29 citations, directly addresses the critical global challenge of rising antibiotic resistance, particularly in the treatment of *H. pylori*—a pathogen linked to severe gastric diseases, including cancer. By pioneering alternative, non-antibiotic approaches, Checcucci’s research offers a promising pathway to reduce reliance on conventional therapies and mitigate treatment failures. His achievements highlight the translational potential of photodynamic principles in clinical microbiology, positioning him as a key figure in the intersection of photonics and infectious disease management.

Research Focus

Key Achievements

1
H-Index
1
Papers
29
Total Citations
29
Avg Citations/Paper
🏆 Most Cited Paper
The in vitro Photoinactivation of Helicobacter pylori by a Novel LED-Based Device
29 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: National Enterprise for NanoScience and NanoTechnology

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago